Glypican-3 vaccine as an adjuvant therapy for hepatocellular carcinoma patients can prolong their overall survival

被引：0
|
作者：
Taniguchi, Masatake [1 ]
Sawada, Yu [2 ]
Yoshikawa, Toshiaki [2 ]
Mizuno, Shoichi [2 ]
Nakatsura, Tetsuya [1 ]
机构：
[1] Kumamoto Univ, Grad Sch, Dept Med Oncol & Translat Res, Div Canc Immunotherapy,Natl Canc Ctr, Kumamoto, Japan
[2] Kumamoto Univ, Natl Canc Ctr, Div Canc Immunotherapy, Kumamoto, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3205
引用
收藏
页码：1333 / 1333
页数：1
相关论文
共 50 条
  • [31] Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Noncovich, Alain
    Guest, Matt
    Kim, Daniel
    Salvador, Katrina
    Richardson, Samantha
    Miller, Terra
    Han, Guangzhou
    Bhat, Abhijit
    Song, Kenneth
    Li, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 586 - 592
  • [32] A CAR-T CELL THERAPY TARGETING GLYPICAN-3 POSITIVE HEPATOCELLULAR CARCINOMA
    Wang, B.
    Ngoh, E.
    Soh, M. K.
    Yeap, Y.
    Huang, H.
    Tan, H. C.
    Hu, Y.
    Wang, C. I.
    HUMAN GENE THERAPY, 2018, 29 (11) : A16 - A16
  • [33] Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
    Kaseb, Ahmed Omar
    Hassan, Manal
    Lacin, Sahin
    Abdel-Wahab, Reham
    Amin, Hesham M.
    Shalaby, Ahmed
    Wolff, Robert A.
    Yao, James
    Rashid, Asif
    Vennapusa, Bharathi
    Feng, Janine
    Ohtomo, Toshihiko
    ONCOTARGET, 2016, 7 (43) : 69916 - 69926
  • [34] Glypican-3: A novel diagnostic marker for hepatocellular carcinoma.
    Sherman, M
    Filmus, J
    Wanless, I
    Capurro, M
    HEPATOLOGY, 2002, 36 (04) : 692A - 692A
  • [35] Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
    Zhou, Fubo
    Shang, Wenting
    Yu, Xiaoling
    Tian, Jie
    MEDICINAL RESEARCH REVIEWS, 2018, 38 (02) : 741 - 767
  • [36] Glypican-3 A Novel Diagnostic Marker for Hepatocellular Carcinoma and More
    Kandil, Dina H.
    Cooper, Kumarasen
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (02) : 125 - 129
  • [37] ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma
    Kelada, O. J.
    Gutsche, N. T.
    Bell, M.
    Berman, R. M.
    Baidoo, K. E.
    Warner, B. M.
    Szajek, L. P.
    Hong, J.
    Ho, M.
    Choyke, P.
    Escorcia, F. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S180 - S181
  • [38] Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
    Zheng, Xiufeng
    Liu, Xun
    Lei, Yanna
    Wang, Gang
    Liu, Ming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma
    Shirakawa, Hirofumi
    Suzuki, Hitomi
    Shimomura, Manami
    Kojima, Motohiro
    Gotohda, Naoto
    Takahashi, Shinichiro
    Nakagohri, Toshio
    Konishi, Masaru
    Kobayashi, Nobuaki
    Kinoshita, Taira
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2009, 100 (08): : 1403 - 1407
  • [40] Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
    Capurro, M
    Wanless, IR
    Sherman, M
    Deboer, G
    Shi, W
    Miyoshi, E
    Filmus, J
    GASTROENTEROLOGY, 2003, 125 (01) : 89 - 97
12345